Disease | colorectal cancer |
Phenotype | C0025202|melanoma |
Sentences | 2 |
PubMedID- 23555633 | This mutation significantly increases the risk of mortality both in colorectal cancer patients and in patients with malignant melanoma [7]. |
PubMedID- 24076266 | Antitumor activity by gsis and mabs administered as single agent in early phases of clinical trials has been observed in advanced or metastatic thyroid cancer, non-small cell lung cancer, intracranial tumors, sarcoma or desmoid tumors, colorectal cancer with neuroendocrine features, melanoma and ovarian cancer. |
Page: 1